Profil

DALLONS Matthieu


Main Research Fields
Finance
Pharmacy, pharmacology & toxicology
Main Co-authors
Tagliatti, Vanessa 
Colet, Jean-Marie 
Podrecca, Manuel
Schepkens, Corentin 
Alpan, Esma

Publications (total 17)

The most downloaded
6 downloads
Dallons, M. (2016). Evaluation de la cardiotoxicité des anti-inflammatoires non-stéroïdiens par approche métabonomique dans un modèle de rat présensibilisé. Unpublished master thesis, Université de Mons.
Jury: Colet, J.-M. (Promotor), Carlier, S., & Laurent, S. https://hdl.handle.net/20.500.12907/21943
The most cited
2 citations (SCOPUS)
Dallons, M., Alpan, E., Schepkens, C., Tagliatti, V., & Colet, J.-M. (2020). GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells. https://hdl.handle.net/20.500.12907/7970

Dallons, M. (2020). Etude de l'effet protecteur du récepteur GPR91 dans le cadre de la toxicité cardiaque induite par la doxorubicine : de l'approche métabonomique à la validation in vitro sur cellules H9C2. Unpublished doctoral thesis, Université de Mons.
Jury: Tagliatti, V. (Promotor), Tafforeau, L., Colet, J.-M., Decleves, A.-E., Carlier, S., Morel, E., & De Tullio, P.

Dallons, M., Alpan, E., Schepkens, C., Tagliatti, V., & Colet, J.-M. (2020). GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells.
Peer reviewed

Dallons, M. (2020). Les ETFs indiciels répliquant le CAC40 ou le DAX sont-ils plus performants que les fonds communs de placement investis sur ces marchés ? Unpublished master thesis, Université de Mons.
Jury: Pozniak, L. (Promotor), Heldenbergh, A., & Sukadi A Sukadi, E.

Dallons, M., Delcourt, M., Schepkens, C., Podrecca, M., & Colet, J.-M. (2020). A Comparative Study of Rat Urine 1H-NMR Metabolome Changes Presumably Arising from Isoproterenol-Induced Heart Necrosis Versus Clarithromycin-Induced QT Interval Prolongation. Biology.
Peer reviewed

Dallons, M., Schepkens, C., Dupuis, A., Tagliatti, V., & Colet, J.-M. (2020). New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro1H-NMR Metabonomics. Frontiers in Pharmacology.
Peer Reviewed verified by ORBi

Dallons, M., & Tagliatti, V. (31 January 2020). Development and validation of an in vitro fluorimetric quantification method of ROS generation using the DCFH-DA probe to detect quickly the presence of a drug-induced oxidative stress. Poster session presented at 14th meeting of the FRS-FNRS Contact group on oxidative stress and antioxidants, Mons, Belgium.

Dallons, M., & Tagliatti, V. (31 January 2020). Development and validation of an in vitro fluorimetric quantification method of ROS generation using the DCFH-DA probe to detect quickly the presence of a drug-induced oxidative stress. Paper presented at 14th meeting of the FRS-FNRS Contact group on oxidative stress and antioxidants, Mons, Belgium.

Dallons, M., & Tagliatti, V. (21 November 2019). Contribution of in vitro 1H-NMR metabonomics for studying doxorubicin-induced cardiotoxicity and protective effects of dexrazoxane. Paper presented at EMBO-EMBL Symposium - Metabolism Meets Epigenetics 2019, Heidelberg, Germany.

Dallons, M., & Tagliatti, V. (21 November 2019). Contribution of in vitro 1H-NMR metabonomics for studying doxorubicin-induced cardiotoxicity and protective effects of dexrazoxane. Poster session presented at EMBO-EMBL Symposium - Metabolism Meets Epigenetics 2019, Heidelberg, Germany.

Dallons, M., & Tagliatti, V. (23 May 2018). Doxorubicin-induced metabolic alterations in H9C2 cells and effects of preincubation with dexrazoxane, a cardioprotective agent. Paper presented at 11èmes journées scientifiques du RFMF, Liège, Belgium.

Dallons, M., & Tagliatti, V. (23 May 2018). Doxorubicin-induced metabolic alterations in H9C2 cells and effects of preincubation with dexrazoxane, a cardioprotective agent. Poster session presented at 11èmes journées scientifiques du RFMF, Liège, Belgium.

Dallons, M. (05 April 2018). Study of the metabolic doxorubicine-induced alterations in H9C2 cells and the effect of preincubation with dexrazoxane, a cardioprotective agent. Paper presented at 15 International Youth School-Conference 'Magnetic resonance and its applications - Spinus-2018, Saint-Pétersbourg, Russia.

Dallons, M., & Tagliatti, V. (01 April 2018). Study of the metabolic doxorubicine-induced alterations in H9C2 cells and the effect of preincubation with dexrazoxane, a cardioprotective agent. Paper presented at 15 International Youth School-Conference 'Magnetic resonance and its applications - Spinus-2018, Saint-Pétersbourg, Russia.

Dallons, M., Podrecca, M., & Colet, J.-M. (25 April 2017). 1H-NMR based metabonomics as a potential tool to assess cardiotoxicity in drug development. Poster session presented at 14 International Youth School-Conference 'Magnetic resonance and its applications - Spinus-2017', Saint Petersburg, Russia.

Dallons, M., Podrecca, M., & Colet, J.-M. (23 April 2017). 1H-NMR based metabonomics as a potential tool to assess cardiotoxicity in drug development. Paper presented at 14 International Youth School-Conference 'Magnetic resonance and its applications - Spinus-2017', Saint Petersburg, Russia.

Dallons, M., & Colet, J.-M. (07 March 2017). Study of miR-1 involvement in the cardiac alteration of mitochondrial metabolism induced by doxorubicin. Poster session presented at Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium.

Dallons, M. (2016). Evaluation de la cardiotoxicité des anti-inflammatoires non-stéroïdiens par approche métabonomique dans un modèle de rat présensibilisé. Unpublished master thesis, Université de Mons.
Jury: Colet, J.-M. (Promotor), Carlier, S., & Laurent, S.

Contact ORBi